Related Experiment Video
Updated: Jun 20, 2026
10:55
Digital Microfluidics for Automated Proteomic Processing
Published on: November 6, 2009
12.5K
Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
Vikas Sharma1, Amirreza Mottafegh1, Jeong-Un Joo1
1Center for Intelligent Microprocess of Pharmaceutical Synthesis, Department of Chemical Engineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea. dpkim@postech.ac.kr.
Lab on a Chip
|May 16, 2024
Summary
Biopharmaceutical purification is enhanced by microfluidic technology and intelligent systems. These innovations improve efficiency, cost-effectiveness, and regulatory compliance for personalized medicines.
Area of Science:
- Biopharmaceutical Manufacturing
- Biotechnology
- Process Engineering
Background:
- Biopharmaceuticals are vital therapeutics for diseases like cancer and genetic disorders.
- High-quality biologics production requires complex, regulated manufacturing processes, including extensive purification.
- Personalized medicine demands novel, efficient purification technologies.
Purpose of the Study:
- To review the significance, challenges, and prospects of continuous, integrated, and intelligent methodologies in small-scale biopharmaceutical downstream processing.
- To highlight the role of microfluidic technology and intelligent systems in enhancing purification processes.
- To explore how these advancements support personalized precision nano-medicines.
Main Methods:
- Focus on microfluidic technology for precise, compact separation and rapid purification modules.
- Integration of intelligent biomanufacturing systems with miniaturized devices for automation and advanced control.
- Emphasis on continuous, integrated, and intelligent methodologies in downstream processing.
Main Results:
- Microfluidic technology enables precise, compact, and continuous purification.
- Intelligent systems offer automation, real-time monitoring, and improved data management.
- Integration enhances process efficiency, robustness, and regulatory adherence (GMP).
Conclusions:
- Adoption of microfluidics and intelligent systems significantly enhances biopharmaceutical purification.
- These technologies improve efficiency, cost-effectiveness, and regulatory compliance.
- The integration shapes the future of biopharmaceutical production for personalized therapies.
Related Concept Videos
01:27Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
01:29Downstream Processing
Downstream processing begins once fermentation is complete and involves a series of steps to recover and purify products such as acids, vitamins, antibiotics, or proteins.Cell HarvestingFor example, for intracellular protein-based products, the first step is harvesting the cells. This is typically achieved using centrifugation or filtration to separate the cells from the liquid phase.Cell Disruption for Intracellular ProductsIf the target product is intracellular, the harvested cells must be...